Eckert & Ziegler BEBIG

Changes to the Board of Directors. Capital increase by contribution in cash - Seite 2

In accordance with Article 598 of the Company Code, the board of directors decided that the issue price shall amount to EUR 0.88 per new share (i.e. the average trading price of the 30 last days) and as a result of the capital increase decided today, 5,745,646 new shares, without nominal value, were issued, as compensation for the above-mentioned contribution and the share capital of the company was increased to bring it from EUR 10,879,026.72 to EUR 14,439,797,82 EUR

The extraordinary general meeting of shareholders also decided to resolve on (i) a  reverse stock split with a ratio of ten (10) existing shares to one (1) share, with a delegation of powers granted to the board of directors to implement this reverse stock split and (ii) the renewal the authorisation granted to the board of directors to increase the share capital of the company (authorised capital).

About Eckert & Ziegler BEBIG
Contributing to saving lives!
Eckert & Ziegler BEBIG (Euronext: EZBG; Reuters: EZBG.BR; Bloomberg: EZBG:BB) is a European-based group active in the medical device segment of the health care industry. Its core business is the production and distribution of medical products for the treat­ment of cancer using brachytherapy. The company's headquarters are in Belgium, with production facilities in Germany and in the USA, as well as subsidiaries throughout Europe, the USA, India and Brazil. In addition, Eckert & Ziegler BEBIG has a worldwide network of distributors and agents to support the international marketing and distribution of its product line. The company's products and equipment are intended for use by oncologists, radiotherapists, urologists, ophthalmologists and medical physicists. Eckert & Ziegler BEBIG employs approximately 140 people. The company has been listed on the Euronext stock exchange since April 1997.

Contact:

Eckert & Ziegler BEBIG SA
Investor Relations
Tel.: [phone]
E-mail: [e-mail]

---

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Eckert & Ziegler BEBIG via Globenewswire

HUG#2019350